LiberoThera Co.
Latest round
- Series C
Last raised
- Aug 2021
Total raised
- $7.6M
Investors
- 5
About LiberoThera Co.
, Ltd., Ltd. was founded in 2018 in Tokyo, Japan. The company specializes in drug development and has completed a total of 3 deals since its inception., Ltd. specializes in innovative drug development through its proprietary cell-free membrane protein preparation technology and non-natural amino acid incorporation technology. These advanced methodologies facilitate the production of complex membrane proteins that are critical for drug discovery and development, particularly in areas such as cancer treatment and other therapeutic applications. The company's core offerings aim to improve the efficiency and effectiveness of drug candidates, thereby addressing significant medical needs in oncology and potentially other therapeutic areas.LiberoThera operates within a revenue framework that emphasizes partnerships and collaborative research agreements with its clients, predominantly in the biopharmaceutical sector. The firm engages in strategic collaborations that can result in milestone payments and royalties based on the commercial success of developed therapies., Ltd. Specific release dates for new products are yet to be announced.
Who invested in LiberoThera Co.
5 investors across 2 rounds
See all investors in LiberoThera Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about LiberoThera Co.
Who invested in LiberoThera Co.?
LiberoThera Co. has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has LiberoThera Co. raised?
LiberoThera Co. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did LiberoThera Co. last raise money?
LiberoThera Co.'s most recent round on record is a Series C, in Aug 2021.
What does LiberoThera Co. do?
LiberoThera Co. is a pharmaceuticals company.
Where is LiberoThera Co. headquartered?
LiberoThera Co. is headquartered in Tokyo, Japan.
Which VCs invest in companies like LiberoThera Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at LiberoThera Co.'s stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like LiberoThera Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.